Stocks and Investing Stocks and Investing
Thu, December 1, 2022
[ 12:00 AM ] - WOPRAI
Tessa Romero Maintained (AGIO) at Hold with Decreased Target to $33 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Corinne Jenkins Initiated (ALT) at Strong Buy and Held Target at $20 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Betsy Graseck Downgraded (ALLY) to Sell and Decreased Target to $19 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Julian Mitchell Maintained (ALLE) at Buy with Increased Target to $127 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Jared Dinges Maintained (CCEP) at Buy with Increased Target to $67 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Brian Peterson Maintained (BOX) at Buy with Decreased Target to $33 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Corinne Jenkins Upgraded (BTAI) to Hold and Held Target at $16 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Anthony Hau Maintained (SUI) at Strong Buy with Increased Target to $163 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Keith Horowitz Maintained (STT) at Hold with Increased Target to $85 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (STT) at Buy with Increased Target to $86 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Betsy Graseck Downgraded (SYF) to Sell and Decreased Target to $29 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Alec Stranahan Initiated (SWTX) at Strong Buy and Held Target at $45 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Tito Labarta Upgraded (STNE) to Hold and Increased Target to $11 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Alexei Gogolev Initiated (SPNS) at Sell and Held Target at $20 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Chuck Cerankosky Upgraded (SPTN) to Strong Buy on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Brent Bracelin Maintained (SNOW) at Buy with Decreased Target to $200 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Karl Keirstead Maintained (SNOW) at Hold with Decreased Target to $140 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Simon Leopold Maintained (SNOW) at Buy with Decreased Target to $180 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Mike Cikos Maintained (SNOW) at Strong Buy with Decreased Target to $165 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Mark Murphy Maintained (SNOW) at Buy with Decreased Target to $180 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Keith Weiss Maintained (SNOW) at Buy with Decreased Target to $225 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Brad Reback Maintained (SNOW) at Hold with Decreased Target to $150 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Harsh Kumar Maintained (SMTC) at Buy with Decreased Target to $45 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Jason Celino Maintained (SNPS) at Buy with Increased Target to $467 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Adelson Maintained (SOFI) at Hold with Decreased Target to $5 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Duane Pfennigwerth Maintained (AAL) at Hold with Increased Target to $19 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Lincoln Kong Maintained (ZH) at Hold with Decreased Target to $12 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Nigel Coe Downgraded (ZBRA) to Sell on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Nina Marques Initiated (ZS) at Hold and Held Target at $135 on, Dec 1st, 2022
[ 12:00 AM ] - WOPRAI
Corinne Jenkins Initiated (ACRS) at Strong Buy and Held Target at $25 on, Dec 1st, 2022

Corinne Jenkins Initiated (ACRS) at Strong Buy and Held Target at $25 on, Dec 1st, 2022


Published on 2024-10-28 00:23:42 - WOPRAI, Corinne Jenkins
  Print publication without navigation


Corinne Jenkins of Goldman Sachs, Initiated "Aclaris Therapeutics, Inc." (ACRS) at Strong Buy and Held Target at $25 on, Dec 1st, 2022.

Corinne has made no other calls on ACRS in the last 4 months.



There is 1 other peer that has a rating on ACRS. Out of the 1 peers that are also analyzing ACRS, 0 agree with Corinne's Rating of Hold.



This is the rating of the analyst that currently disagrees with Corinne

  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $32 on, Thursday, October 6th, 2022
Contributing Sources